Recombinant multi-species DNASE1L3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DNASE1L3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the deoxyribonuclease I family. The encoded protein hydrolyzes DNA, is not inhibited by actin, and mediates the breakdown of DNA during apoptosis. Mutations in this gene are a cause of systemic lupus erythematosus-16. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Feb 2012]
The Alternative Names of target: DNASE1L3,Deoxyribonuclease gamma,DNase gamma,DNase I homolog protein DHP2, Deoxyribonuclease I-like 3 (DNase I-like 3), Liver and spleen DNase (LS-DNase, LSD),D3,LSD,DHP2,SLEB16,DNAS1L3

Target products collectionGo to DNASE1L3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0893-Ab-1/ GM-Tg-hg-SE0893-Ab-2 Human DNASE1L3 protein Human
GM-Tg-rg-SE0893-Ab-1/ GM-Tg-rg-SE0893-Ab-2 Rat DNASE1L3 protein Rat
GM-Tg-mg-SE0893-Ab-1/ GM-Tg-mg-SE0893-Ab-2 Mouse DNASE1L3 protein Mouse
GM-Tg-cynog-SE0893-Ab-1/ GM-Tg-cynog-SE0893-Ab-2 Cynomolgus/Rhesus macaque DNASE1L3 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0893-Ab-1/ GM-Tg-felg-SE0893-Ab-2 Feline DNASE1L3 protein Feline
GM-Tg-cang-SE0893-Ab-1/ GM-Tg-cang-SE0893-Ab-2 Canine DNASE1L3 protein Canine
GM-Tg-bovg-SE0893-Ab-1/ GM-Tg-bovg-SE0893-Ab-2 Bovine DNASE1L3 protein Bovine
GM-Tg-equg-SE0893-Ab-1/ GM-Tg-equg-SE0893-Ab-2 Equine DNASE1L3 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0893-Ab-1/ GM-Tg-hg-SE0893-Ab-2; GM-Tg-rg-SE0893-Ab-1/ GM-Tg-rg-SE0893-Ab-2;
GM-Tg-mg-SE0893-Ab-1/ GM-Tg-mg-SE0893-Ab-2; GM-Tg-cynog-SE0893-Ab-1/ GM-Tg-cynog-SE0893-Ab-2;
GM-Tg-felg-SE0893-Ab-1/ GM-Tg-felg-SE0893-Ab-2; GM-Tg-cang-SE0893-Ab-1/ GM-Tg-cang-SE0893-Ab-2;
GM-Tg-bovg-SE0893-Ab-1/ GM-Tg-bovg-SE0893-Ab-2; GM-Tg-equg-SE0893-Ab-1/ GM-Tg-equg-SE0893-Ab-2
Products Name DNASE1L3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name DNASE1L3
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DNASE1L3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.